Erratum: The Effect of the Presence of Fibromyalgia on Common Clinical Disease Activity Indices in Patients with Psoriatic Arthritis: A Cross-sectional Study (Journal of Rheumatology (2016) DOI: 10.3899/jrheum.151491);The effect of the presence of fibromyalgia on common clinical disease activity indices in patients with psoriatic arthritis: A cross-sectional study

Journal of Rheumatology

Volumn 43, Issue 9, 2016, Pages 1749-1754

  Brikman, Shay ^a   Furer, Victoria ^a   Wollman, Jonathan ^a   Borok, Sara ^a   Matz, Hagit ^a   Polachek, Arik ^a   Elalouf, Ofir ^a   Sharabi, Amir ^a   Kaufman, Ilana ^a   Paran, Daphna ^a   Elkayam, Ori ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Disease activity indices; Fibromyalgia; Psoriatic arthritis

Indexed keywords

AGE DISTRIBUTION; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPOSITE PSORIATIC DISEASE ACTIVITY INDEX; CROSS-SECTIONAL STUDY; DERMATOLOGY LIFE QUALITY INDEX; DISEASE ACTIVITY; DISEASE ACTIVITY INDEX FOR PSORIATIC ARTHRITIS SCORE; DISEASE ASSESSMENT; DISEASE DURATION; FEMALE; FIBROMYALGIA; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MALE; MINIMAL DISEASE ACTIVITY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIATIC ARTHRITIS; SCORING SYSTEM; ADULT; AGED; COMPLICATION; MIDDLE AGED; QUALITY OF LIFE; REMISSION; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; ARTHRITIS, PSORIATIC; CROSS-SECTIONAL STUDIES; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX;

EID: 84985019788     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.151491.C1     Document Type: Erratum

References (33)

1. Salvarani C, Lo Scocco G, Macchioni P, Cremonesi T, Rossi F, Mantovani W, et al. Prevalence of psoriatic arthritis in Italian psoriatic patients. J Rheumatol 1995;22:1499-503.
2. McCarey D, McInnes IB. Psoriatic arthritis: current topics. Curr Rheumatol Rep 2007;9:442-8.
3. Setty AR, Choi HK. Psoriatic arthritis epidemiology. Curr Rheumatol Rep 2007;9:449-54.
4. Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69:631-7.
5. Smolen JS, Braun J, Dougados M, Emery P, Fitzgerald O, Helliwell P. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis 2014;73:6-16.
6. Wong PC, Leung YY, Li EK, Tam LS. Measuring disease activity in psoriatic arthritis. Int J Rheumatol 2012;2012:839425.
7. FitzGerald O, Helliwell P, Mease P, Mumtaz A, Coates L, Pedersen R, et al. Application of composite disease activity scores in psoriatic arthritis to the PRESTA data set. Ann Rheum Dis 2012;71:358-62.
8. Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978;157:238-44.
9. Coates LC, Fransen J, Helliwell PS. Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis 2010;69:48-53.
10. Coates LC, Helliwell PS. Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data. Arthritis Care Res 2010;62:965-9.
11. Coates LC, Navarro-Coy N, Brown SR, Brown S, McParland L, Collier H, et al. The TICOPA protocol (TIght COntrol of psoriatic arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis. BMC Musculoskelet Disord 2013;14:101.
12. Coates LC, Moverley AR, McParland L, Brown S, Collier H, Law J, et al. Results of a randomised controlled trial comparing tight control of early psoriatic arthritis (TICOPA) with standard care: tight control improves outcome [abstract]. Arthritis Rheum 2013;65 Suppl 10:S346.
13. Schoels M, Aletaha D, Funovits J, Kavanaugh A, Baker D, Smolen JS. Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis. Ann Rheum Dis 2010; 69:1441-7.
14. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
15. Fransen J, Antoni C, Mease PJ, Uter W, Kavanaugh A, Kalden JR, et al. Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors. Ann Rheum Dis 2006;65:1373-8.
16. Salaffi F, De Angelis R, Grassi W. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol 2005;23:819-28.
17. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
18. Marchesoni A, Atzeni F, Spadaro A, Lubrano E, Provenzano G, Cauli A, et al. Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia. J Rheumatol 2012;39:849-55.
19. Buskila D, Langevitz P, Gladman DD, Urowitz S, Smythe HA. Patients with rheumatoid arthritis are more tender than those with psoriatic arthritis. J Rheumatol 1992;19:1115-9.
20. Salaffi F, De Angelis R, Carotti M, Gutierrez M, Sarzi-Puttini P, Atzeni F. Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity. Rheumatol Int 2014;34:1103-10.
21. Graceffa D, Maiani E, Sperduti I, Ceralli F, Bonifati C. Clinical remission of psoriatic arthritis in patients receiving continuous biological therapies for 1 year: the experience of an outpatient dermatological clinic for psoriasis. Clin Exp Dermatol 2015; 40:136-41.
22. Husted JA, Thavaneswaran A, Chandran V, Gladman DD. Incremental effects of comorbidity on quality of life in patients with psoriatic arthritis. J Rheumatol 2013;40:1349-56.
23. Magrey NM, Antonelli M, James N, Khan MS. High frequency of fibromyalgia in patients with psoriatic arthritis: a pilot study. Arthritis 2013;2013:762921.
24. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H; CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73.
25. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010;62:600-10.
26. Wolfe F, Häuser W. Fibromyalgia diagnosis and diagnostic criteria. Ann Med 2011;43:495-502.
27. Segura-Jiménez V, Aparicio VA, Álvarez-Gallardo IC, Soriano-Maldonado A, Estévez-López F, Delgado-Fernández M, et al. Validation of the modified 2010 American College of Rheumatology diagnostic criteria for fibromyalgia in a Spanish population. Rheumatology 2014;53:1803-11.
28. Yunus MB. The prevalence of fibromyalgia in other chronic pain conditions. Pain Res Treat 2012;2012:584573.
29. Ranzolin A, Brenol JC, Bredemeier M, Guarienti J, Rizzatti M, Feldman D, et al. Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis. Arthritis Rheum 2009;61:794-800.
30. Azevedo VF, Paiva Edos S, Felippe LR, Moreira RA. Occurrence of fibromyalgia in patients with ankylosing spondylitis. Rev Bras Reumatol 2010;50:646-50.
31. Roussou E, Ciurtin C. Clinical overlap between fibromyalgia tender points and enthesitis sites in patients with spondyloarthritis who present with inflammatory back pain. Clin Exp Rheumatol 2012;30 Suppl 74:24-30.
32. Marchesoni A, De Lucia O, Rotunno L, De Marco G, Manara M. Entheseal power Doppler ultrasonography: a comparison of psoriatic arthritis and fibromyalgia. J Rheumatol Suppl. 2012 Jul;89:29-31.
33. Kavanaugh A, van der Heijde D, Beutler A, Gladman D, Mease P, Krueger GG, et al. Radiographic progression of patients with psoriatic arthritis who achieve minimal disease activity in response to golimumab therapy: results through 5 years of a randomized, placebo-controlled study. Arthritis Care Res 2016;68:267-74.